Global Therapeutic Drug Monitoring Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Therapeutic Drug Monitoring Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Therapeutic Drug Monitoring Market Overview:
Global Therapeutic Drug Monitoring Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Therapeutic Drug Monitoring involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Therapeutic Drug Monitoring Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Therapeutic Drug Monitoring market in 2020.
Global Therapeutic Drug Monitoring Market Segmentation
By Type, Therapeutic Drug Monitoring market has been segmented into:
Blood test
Urine test
Saliva test
Other test
By Application, Therapeutic Drug Monitoring market has been segmented into:
Hospital Laboratories
Commercial/Private Laboratories
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Therapeutic Drug Monitoring market are:
F. Hoffmann-La Roche AG
Siemens Healthcare
Thermo Fisher Scientific
Bio-Rad Laboratories Inc.
Danaher Corporation
1. Market Overview of Therapeutic Drug Monitoring
1.1 Therapeutic Drug Monitoring Market Overview
1.1.1 Therapeutic Drug Monitoring Product Scope
1.1.2 Market Status and Outlook
1.2 Therapeutic Drug Monitoring Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Therapeutic Drug Monitoring Historic Market Size by Regions (2015-2020)
1.4 Therapeutic Drug Monitoring Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Therapeutic Drug Monitoring Sales Market by Type (2015-2026)
2.1 Global Therapeutic Drug Monitoring Historic Market Size by Type (2015-2020)
2.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Type (2021-2026)
2.3 Blood test
2.4 Urine test
2.5 Saliva test
2.6 Other test
3. Covid-19 Impact Therapeutic Drug Monitoring Sales Market by Application (2015-2026)
3.1 Global Therapeutic Drug Monitoring Historic Market Size by Application (2015-2020)
3.2 Global Therapeutic Drug Monitoring Forecasted Market Size by Application (2021-2026)
3.3 Hospital Laboratories
3.4 Commercial/Private Laboratories
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Therapeutic Drug Monitoring Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Therapeutic Drug Monitoring Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Therapeutic Drug Monitoring Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Therapeutic Drug Monitoring Business
5.1 F. Hoffmann-La Roche AG
5.1.1 F. Hoffmann-La Roche AG Company Profile
5.1.2 F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Product Specification
5.1.3 F. Hoffmann-La Roche AG Therapeutic Drug Monitoring Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Siemens Healthcare
5.2.1 Siemens Healthcare Company Profile
5.2.2 Siemens Healthcare Therapeutic Drug Monitoring Product Specification
5.2.3 Siemens Healthcare Therapeutic Drug Monitoring Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Company Profile
5.3.2 Thermo Fisher Scientific Therapeutic Drug Monitoring Product Specification
5.3.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Bio-Rad Laboratories Inc.
5.4.1 Bio-Rad Laboratories Inc. Company Profile
5.4.2 Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Product Specification
5.4.3 Bio-Rad Laboratories Inc. Therapeutic Drug Monitoring Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Danaher Corporation
5.5.1 Danaher Corporation Company Profile
5.5.2 Danaher Corporation Therapeutic Drug Monitoring Product Specification
5.5.3 Danaher Corporation Therapeutic Drug Monitoring Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Therapeutic Drug Monitoring Market Size (2015-2026)
6.2 North America Therapeutic Drug Monitoring Key Players in North America (2015-2020)
6.3 North America Therapeutic Drug Monitoring Market Size by Type (2015-2020)
6.4 North America Therapeutic Drug Monitoring Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Therapeutic Drug Monitoring Market Size (2015-2026)
7.2 East Asia Therapeutic Drug Monitoring Key Players in North America (2015-2020)
7.3 East Asia Therapeutic Drug Monitoring Market Size by Type (2015-2020)
7.4 East Asia Therapeutic Drug Monitoring Market Size by Application (2015-2020)
8. Europe
8.1 Europe Therapeutic Drug Monitoring Market Size (2015-2026)
8.2 Europe Therapeutic Drug Monitoring Key Players in North America (2015-2020)
8.3 Europe Therapeutic Drug Monitoring Market Size by Type (2015-2020)
8.4 Europe Therapeutic Drug Monitoring Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Therapeutic Drug Monitoring Market Size (2015-2026)
9.2 South Asia Therapeutic Drug Monitoring Key Players in North America (2015-2020)
9.3 South Asia Therapeutic Drug Monitoring Market Size by Type (2015-2020)
9.4 South Asia Therapeutic Drug Monitoring Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Therapeutic Drug Monitoring Market Size (2015-2026)
10.2 Southeast Asia Therapeutic Drug Monitoring Key Players in North America (2015-2020)
10.3 Southeast Asia Therapeutic Drug Monitoring Market Size by Type (2015-2020)
10.4 Southeast Asia Therapeutic Drug Monitoring Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Therapeutic Drug Monitoring Market Size (2015-2026)
11.2 Middle East Therapeutic Drug Monitoring Key Players in North America (2015-2020)
11.3 Middle East Therapeutic Drug Monitoring Market Size by Type (2015-2020)
11.4 Middle East Therapeutic Drug Monitoring Market Size by Application (2015-2020)
12. Africa
12.1 Africa Therapeutic Drug Monitoring Market Size (2015-2026)
12.2 Africa Therapeutic Drug Monitoring Key Players in North America (2015-2020)
12.3 Africa Therapeutic Drug Monitoring Market Size by Type (2015-2020)
12.4 Africa Therapeutic Drug Monitoring Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Therapeutic Drug Monitoring Market Size (2015-2026)
13.2 Oceania Therapeutic Drug Monitoring Key Players in North America (2015-2020)
13.3 Oceania Therapeutic Drug Monitoring Market Size by Type (2015-2020)
13.4 Oceania Therapeutic Drug Monitoring Market Size by Application (2015-2020)
14. South America
14.1 South America Therapeutic Drug Monitoring Market Size (2015-2026)
14.2 South America Therapeutic Drug Monitoring Key Players in North America (2015-2020)
14.3 South America Therapeutic Drug Monitoring Market Size by Type (2015-2020)
14.4 South America Therapeutic Drug Monitoring Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Therapeutic Drug Monitoring Market Size (2015-2026)
15.2 Rest of the World Therapeutic Drug Monitoring Key Players in North America (2015-2020)
15.3 Rest of the World Therapeutic Drug Monitoring Market Size by Type (2015-2020)
15.4 Rest of the World Therapeutic Drug Monitoring Market Size by Application (2015-2020)
16 Therapeutic Drug Monitoring Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Therapeutic Drug Monitoring Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|